PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Moxetumomab Pasudotox-tdfk Injection

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.


Moxetumomab pasudotox-tdfk is a medication used to treat certain types of leukemia, specifically hairy cell leukemia. Like all medications, it comes with potential risks and side effects. Here are some of the risks associated with taking Moxetumomab pasudotox-tdfk injection:

  • Infusion Reactions: Patients may experience infusion-related reactions, including fever, chills, nausea, and low blood pressure, during or shortly after receiving the injection.
  • Capillary Leak Syndrome: This is a serious side effect that can occur with Moxetumomab pasudotox-tdfk. It involves the leaking of fluid from small blood vessels into surrounding tissues, leading to swelling, low blood pressure, and potential organ damage.
  • Liver Toxicity: Elevated liver enzyme levels and liver damage have been reported in some patients taking this medication. Regular monitoring of liver function is important.
  • Fluid Retention: Some individuals may experience fluid retention, leading to swelling, weight gain, and difficulty breathing.
  • Skin Reactions: Skin problems, such as rash, itching, and redness, may occur as a side effect.
  • Hypersensitivity Reactions: Allergic reactions to the medication can occur, with symptoms ranging from rash and itching to more severe reactions like difficulty breathing or anaphylaxis.
  • Decreased Blood Cell Counts: Moxetumomab pasudotox-tdfk can lower the levels of various blood cells, including red blood cells, white blood cells, and platelets, which can increase the risk of infection, anemia, and bleeding.
  • Kidney Problems: Some patients may experience kidney dysfunction while taking this medication.
  • Eye Problems: Vision changes, such as blurred vision, may occur in some individuals.
  • Other Side Effects: Additional side effects can include fatigue, nausea, diarrhea, headache, and abdominal pain.

It’s important for individuals prescribed Moxetumomab pasudotox-tdfk to closely follow their healthcare provider’s instructions, receive regular check-ups, and report any unusual symptoms or side effects promptly. The benefits of the medication should be weighed against the potential risks, and healthcare providers will monitor patients carefully to manage and mitigate these risks during treatment. This medication should only be used under the supervision of a qualified healthcare professional who can assess its appropriateness for the individual patient’s condition and monitor their response to treatment.

Why is this medication prescribed?

Moxetumomab pasudotox-tdfk injection is prescribed to treat a specific type of leukemia called hairy cell leukemia (HCL) in adult patients who have received at least two prior lines of therapy. HCL is a rare, slow-growing blood cancer that affects white blood cells called B lymphocytes. This medication is typically recommended when other treatments have not been effective or have stopped working.

How should this medicine be used?

Here’s how Moxetumomab pasudotox-tdfk injection is typically used:

  • Administration: The medication is given by intravenous (IV) infusion, which means it is administered directly into a vein in your arm by a healthcare professional.
  • Dosage: The dosage of Moxetumomab pasudotox-tdfk can vary depending on your individual medical condition and response to treatment. Your healthcare provider will determine the appropriate dose and treatment schedule for you.
  • Treatment Course: Treatment with Moxetumomab pasudotox-tdfk is usually given over a course of several weeks, with specific dosing schedules. It may consist of multiple cycles, and the duration of treatment will be determined by your healthcare team.
  • Monitoring: During treatment, your healthcare provider will monitor your progress closely. This includes regular blood tests to check for changes in your blood cell counts, liver function, and kidney function.
  • Adverse Effects Management: Be aware of potential side effects and report any unusual symptoms to your healthcare provider promptly. They will help manage and address any side effects that may occur during treatment.
  • Precautions: It’s important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments. Inform your healthcare team about any other medications, supplements, or health conditions you have, as they can interact with Moxetumomab pasudotox-tdfk.
  • Safety Precautions: Due to potential side effects and the risk of infusion reactions, Moxetumomab pasudotox-tdfk is typically administered in a medical facility equipped to handle emergencies. Patients should be monitored during and after infusion.

It’s crucial to have open and regular communication with your healthcare provider regarding your treatment with Moxetumomab pasudotox-tdfk. They will assess your response to the medication and make any necessary adjustments to your treatment plan.

Please note that the information provided here is for general guidance, and individual treatment plans may vary. Always follow your healthcare provider’s recommendations and guidelines for using this medication.

Other uses for this medicine

Moxetumomab pasudotox-tdfk is a medication used for the treatment of hairy cell leukemia (HCL), a rare type of blood cancer. It works by targeting and killing specific cells in the body. Always consult with your healthcare provider for the most up-to-date and accurate information regarding its uses.

What special precautions should I follow?

Regarding special precautions for moxetumomab pasudotox-tdfk injection, here are some general guidelines:

  • Medical Supervision: Moxetumomab pasudotox-tdfk should be administered by a healthcare professional in a clinical setting, typically in a hospital or clinic, due to potential side effects and the need for careful monitoring.
  • Allergic Reactions: Inform your healthcare provider about any known allergies or hypersensitivity to any of the ingredients in the medication. Be vigilant for signs of an allergic reaction during and after the infusion, such as rash, itching, swelling, dizziness, or difficulty breathing.
  • Fluid Intake: Ensure you are adequately hydrated before and after the infusion. Your healthcare provider may recommend intravenous fluids to help manage potential side effects like kidney problems.
  • Kidney and Liver Function: Your healthcare provider will monitor your kidney and liver function regularly during treatment. Any abnormalities may require dose adjustments or discontinuation of the medication.
  • Vision Changes: Moxetumomab pasudotox-tdfk can cause visual disturbances, such as blurred vision or changes in color vision. If you experience any vision changes, report them to your healthcare provider promptly.
  • Skin Reactions: Skin reactions, such as rash, itching, or redness, may occur. Inform your healthcare provider if you experience any skin changes.
  • Infections: Since moxetumomab pasudotox-tdfk can affect your immune system, you may be at an increased risk of infections. Report any signs of infection (e.g., fever, sore throat, cough) to your healthcare provider.
  • Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of moxetumomab pasudotox-tdfk with your healthcare provider. It may not be safe during pregnancy or while breastfeeding.
  • Contraception: Effective contraception is essential for both males and females during and for some time after treatment, as the medication may affect fertility.
  • Interactions: Inform your healthcare provider about all medications, supplements, and herbal products you are taking, as some may interact with moxetumomab pasudotox-tdfk.

Please note that these precautions are general guidelines, and individualized recommendations may vary based on your specific medical condition and treatment plan. Always follow your healthcare provider’s advice and closely adhere to their instructions for moxetumomab pasudotox-tdfk treatment.

What special dietary instructions should I follow?

There are generally no specific dietary restrictions associated with Moxetumomab Pasudotox-tdfk. However, you should maintain a balanced and healthy diet to support your overall well-being and immune system.

What should I do if I forget a dose?

  • Since Moxetumomab Pasudotox-tdfk is administered by a healthcare professional, you are less likely to forget a dose on your own. The medication is typically given on a schedule determined by your healthcare provider.
  • If you suspect you missed a dose or if there were any issues with the infusion process, contact your healthcare provider immediately. They will provide guidance on how to proceed.

What side effects can this medication cause?

Common side effects of moxetumomab pasudotox-tdfk can include:

  • Swelling and Edema: Swelling in the arms, legs, or other parts of the body is a common side effect.
  • Nausea: Some people may experience nausea or vomiting.
  • Fatigue: Feeling tired or fatigued is a common side effect during and after treatment.
  • Headache: Headaches can occur as a side effect.
  • Fever: Fever is a possible side effect and may be a sign of infection.
  • Abdominal Pain: Some people may experience abdominal pain or discomfort.
  • Decreased Appetite: Loss of appetite or decreased food intake may occur.
  • Skin Reactions: Rash, itching, or redness of the skin can occur.
  • Vision Changes: Changes in vision, including blurred vision or changes in color vision, have been reported.
  • Kidney and Liver Problems: Moxetumomab pasudotox-tdfk can affect kidney and liver function. Your healthcare provider will monitor your blood tests to assess these functions.
  • Infections: The medication can weaken the immune system, making you more susceptible to infections. If you develop signs of infection, such as fever, cough, or sore throat, it’s important to inform your healthcare provider promptly.
  • Low Blood Cell Counts: Moxetumomab pasudotox-tdfk may cause a decrease in red blood cell, white blood cell, and platelet counts, which can lead to anemia, increased risk of infection, and bleeding.
  • Fluid Retention: Retaining fluid in your body can be a side effect, leading to swelling and weight gain.

It’s essential to report any side effects you experience to your healthcare provider promptly. They can provide guidance on managing these side effects and may adjust your treatment plan if necessary.

Always consult with your healthcare provider for the most current and detailed information on the potential side effects of moxetumomab pasudotox-tdfk and how to manage them during your treatment. Your healthcare provider can help you weigh the benefits of the medication against the potential risks and side effects to make informed treatment decisions.

What should I know about storage and disposal of this medication?


  • Storage Location: Moxetumomab Pasudotox-tdfk is typically stored by healthcare professionals in a clinical setting, such as a hospital or healthcare facility. It is not meant for personal storage at home.
  • Temperature: It should be stored according to the manufacturer’s recommendations and in compliance with local regulations. Typically, medications like this are stored at controlled room temperature, away from extreme heat or cold.
  • Packaging: Ensure that the medication is stored in its original packaging and protected from light and moisture.


  • Disposal by Healthcare Professionals: Healthcare professionals are responsible for the proper disposal of medical waste, including used vials, syringes, and other materials associated with Moxetumomab Pasudotox-tdfk administration. They will follow standard medical waste disposal protocols.
  • Do Not Dispose at Home: Do not attempt to dispose of Moxetumomab Pasudotox-tdfk or its associated waste materials at home. This medication should only be handled by trained healthcare personnel.

In case of emergency/overdose

In case of an emergency or suspected overdose with moxetumomab pasudotox-tdfk, take the following steps:

  • Contact Healthcare Provider: Immediately contact your healthcare provider or seek emergency medical attention. Provide them with all relevant information about the medication and the situation.
  • Poison Control: If you are in the United States, you can also contact the Poison Control Center at 1-800-222-1222 for guidance.
  • Symptom Management: Follow the guidance provided by medical professionals. Treatment for overdose may involve managing symptoms and providing supportive care as necessary.

What other information should I know

  • Follow Instructions: Always follow your healthcare provider’s instructions for the administration of moxetumomab pasudotox-tdfk. Do not attempt to administer the medication on your own.
  • Regular Monitoring: You will be closely monitored by healthcare professionals during treatment to check for any potential side effects, evaluate your response to treatment, and make necessary adjustments.
  • Pregnancy and Contraception: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of this medication with your healthcare provider. Adequate contraception may be necessary during treatment.
  • Medication Interactions: Inform your healthcare provider about all medications, supplements, and herbal products you are taking, as some may interact with moxetumomab pasudotox-tdfk.
  • Patient Education: Make sure you understand the purpose of the medication, the expected benefits, potential side effects, and any special precautions related to your specific treatment plan.
  • Follow-up Appointments: Attend all scheduled follow-up appointments with your healthcare provider to monitor your progress and address any concerns or questions.

Always consult with your healthcare provider or treatment team for the most current and specific information regarding moxetumomab pasudotox-tdfk treatment and its management. These guidelines are general in nature and may be subject to updates or changes based on the latest medical recommendations and research.

Copyright © 2023